The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
CD14 Is an Acute-Phase Protein
Abstract
The origin of soluble CD14 (sCD14) in the circulation is uncertain. To examine whether CD14 could be an acute-phase protein (APP), the levels of sCD14, IL-6, and C-reactive protein were determined by ELISA in serum and synovial fluid (SF) of patients with various arthropathies, and the regulation of CD14 synthesis was examined in liver cells. In patients with crystal-mediated or immunologically mediated arthritis (rheumatoid arthritis), serum levels of sCD14 were higher than or similar to those found in infection-mediated arthritis (reactive arthritis), precluding a relation with bacteria exposure. Levels of sCD14 were similar in SF and serum, and did not correlate with the number of SF leukocytes, excluding an important source from leukocyte membrane-bound CD14, by protease-mediated shedding. In contrast, serum levels of sCD14 in patients correlated with those of C-reactive protein, a classical APP, and IL-6, a cytokine known to regulate the synthesis of APP in the liver. Serum levels of sCD14 also correlated with disease activity in rheumatoid arthritis and reactive arthritis patients. IL-6 stimulated the production of CD14 by HepG2 hepatoma cells. By real-time PCR, the inducibility of CD14 by IL-6 was also observed at the mRNA level both in HepG2 cells and human primary hepatocytes. These in vitro results were confirmed by in vivo studies in IL-6−/− mice injected with turpentine, an experimental model of acute-phase response. Liver levels of CD14 mRNA increased in IL-6+/+, but not in IL-6−/− mice. These results indicate that sCD14 can be considered as a type 2 APP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Self-citationPrevoo, M. L. L., Van'T Hof, M. A., Kuper, H. H., Van Leeuwen, M. A., Van De Putte, L. B. A., & Van Riel, P. L. C. M. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380107 · Cited by 6,243
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,987
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,899
The immunopathogenesis of sepsis
Cohen, J. (2002) · Nature · doi:10.1038/nature01326 · Cited by 2,742
MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4
Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., & Kimoto, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1777 · Cited by 2,185
Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction
Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J., & Gusovsky, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10689 · Cited by 1,924
Interleukin-1 and the Pathogenesis of the Acute-Phase Response
Epstein, F. H., & Dinarello, C. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411293112205 · Cited by 1,146
Pugin, J., Schürer-Maly, C. C., Leturcq, D., Moriarty, A., Ulevitch, R. J., & Tobias, P. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2744 · Cited by 831
CD14 Is a pattern recognition receptor
Pugin, J., Heumann, D., Tomasz, A., Kravchenko, V. V., Akamatsu, Y., Nishijima, M., Glauser, M. P., Tobias, P. S., & Ulevitch, R. J. (1994) · Immunity · doi:10.1016/1074-7613(94)90093-0 · Cited by 699
Soluble CD14 participates in the response of cells to lipopolysaccharide.
Frey, E. A., Miller, D. S., Jahr, T. G., Sundan, A., Bazil, V, Espevik, T., Finlay, B. B., & Wright, S. D. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1665 · Cited by 682
Haziot, A., Chen, S., Ferrero, E., Low, M. G., Silber, R., & Goyert, S. M. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.2.547 · Cited by 645
The soluble interleukin 6 receptor: mechanisms of production and implications in disease
JONES, S. A., HORIUCHI, S., TOPLEY, N., YAMAMOTO, N., & FULLER, G. M. (2001) · The FASEB Journal · doi:10.1096/fj.99-1003rev · Cited by 623
Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression.
Perlmutter, D. H., Dinarello, C. A., Punsal, P. I., & Colten, H. R. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112721 · Cited by 574
Kol, A., Lichtman, A. H., Finberg, R. W., Libby, P., & Kurt-Jones, E. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.13 · Cited by 554
The acute phase response and innate immunity of fish
Bayne, C. J., & Gerwick, L. (2001) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(01)00033-7 · Cited by 469
Toll-like receptors; their physiological role and signal transduction system
Takeuchi, O., & Akira, S. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00010-8 · Cited by 466
Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes
Bazil, V, & Strominger, J. L. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.5.1567 · Cited by 424
Verhasselt, V, Buelens, C., Willems, F., De Groote, D., Haeffner-Cavaillon, N., & Goldman, M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2919 · Cited by 421
Baumann, H., Richards, C., & Gauldie, J. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.12.4122 · Cited by 351
Baumann, H., & Gauldie, J. (1990) · PubMed · Cited by 326
Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein.
Gabay, C., Smith, M. F., Eidlen, D., & Arend, W. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119488 · Cited by 319
Self-citationDentener, M. A., Bazil, V, Von Asmuth, E. J., Ceska, M., & Buurman, W. A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.7.2885 · Cited by 318
Cytokines and the Hepatic Acute-Phase Response
Ramadori, G., & Christ, B. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007106 · Cited by 299
Cellular Events Mediated by Lipopolysaccharide-stimulated Toll-like Receptor 4
Yang, H., Young, D. W., Gusovsky, F., & Chow, J. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002896200 · Cited by 269
Stimulation of Hepatic Acute Phase Response by Cytokines and Glucocorticoidsa
BAUMANN, H., PROWSE, K. R., MARINKOVIĆ, S., WON, K., & JAHREIS, G. P. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb24021.x · Cited by 240
Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids.
Yu, B., Hailman, E., & Wright, S. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119160 · Cited by 225
Baumann, H., Onorato, V, Gauldie, J., & Jahreis, G. P. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47999-9 · Cited by 222
Schumann, R. R., Kirschning, C. J., Unbehaun, A., Aberle, H., Knopf, H.-P., Lamping, N., Ulevitch, R. J., & Herrmann, F. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3490 · Cited by 217
Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide.
Haziot, A., Rong, G. W., Silver, J., & Goyert, S. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1500 · Cited by 204
Kitchens, R. L., Thompson, P. A., Viriyakosol, S., O’Keefe, G. E., & Munford, R. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13139 · Cited by 199
CD14 signalling in lipid rafts: new ligands and co-receptors
Schmitz, G., & Orsó, E. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00007 · Cited by 196
Human Keratinocytes Express Functional CD14 and Toll-Like Receptor 4
Song, P. I., Neparidze, N., Armstrong, C. A., Ansel, J. C., Park, Y.-M., Abraham, T., Harten, B., & Zivony, A. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01847.x · Cited by 196
Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing?
Netea, M. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00079-6 · Cited by 195
Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation
Tobias, P. S., & Ulevitch, R. J. (1993) · Immunobiology · doi:10.1016/s0171-2985(11)80341-4 · Cited by 178
Ganapathi, M. K., Rzewnicki, D., Samols, D., Jiang, S. L., & Kushner, I. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.4.1261 · Cited by 171
Murine CD14 gene expression in vivo: extramyeloid synthesis and regulation by lipopolysaccharide.
Fearns, C., Kravchenko, V. V., Ulevitch, R. J., & Loskutoff, D. J. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.857 · Cited by 157
Haziot, A., Rong, G. W., Bažil, V., Silver, J. E., & Goyert, S. M. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.12.5868 · Cited by 147
Funda, D., Tučková, L., Farré, M., Iwase, T., Moro, I., & Tlaskalova-Hogenova, H. (2001) · Infection and Immunity · doi:10.1128/iai.69.6.3772-3781.2001 · Cited by 147
Khovidhunkit, W., Moser, A. H., Shigenaga, J. K., Grünfeld, C., & Feingold, K. R. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300100-jlr200 · Cited by 145
Durieux, J., Vita, N., Popescu, O., Guette, F., Calzada‐Wack, J., Munker, R., Schmidt, R. E., Lupker, J. H., Ferrara, P., Ziegler‐Heitbrock, H. W. L., et al. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240911 · Cited by 144
Hu, X., Yee, E., Harlan, J. M., Wong, F., & Karsan, A. (1998) · Blood · doi:10.1182/blood.v92.8.2759 · Cited by 140
Soluble CD14 acts as a negative regulator of human T cell activation and function
Nores, J. E. R., Bensussan, A., Vita, N., Stelter, F., Arias, M. A., Jones, M., Lefort, S., Borysiewicz, L. K., Ferrara, P., & Labéta, M. O. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199901)29:01<265::aid-immu265>3.0.co;2-g · Cited by 138
Serum CD14 levels in poly traumatized and severely burned patients
Krüger, C., Schütt, C., Obertacke, U., et al. (1991) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1991.tb05722.x · Cited by 137
Read, M. A., Cordle, S. R., Veach, R. A., Carlisle, C., & Hawiger, J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.9887 · Cited by 130
Bufler, P., Stiegler, G., Schuchmann, M., Hess, S., Krüger, C., Stelter, F., Eckerskorn, C., Schütt, C., & Engelmann, H. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250244 · Cited by 129
Lipopolysaccharide binding protein expression in primary human hepatocytes and HepG2 hepatoma cells.
Grube, B. J., Cochane, C., Ye, R. D., Green, C. E., McPhail, M. E., Ulevitch, R. J., & Tobias, P. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37218-6 · Cited by 128
Endotoxin-neutralizing capacity of soluble CD14
Schütt, C., Schilling, T., Grunwald, U., Schönfeld, W., & Krüger, C. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80082-v · Cited by 127
Upregulation of mouse CD14 expression in Kupffer cells by lipopolysaccharide.
Matsuura, K., Ishida, T., Setoguchi, M., Higuchi, Y., Akizuki, S., & Yamamoto, S. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.5.1671 · Cited by 121
Elevated levels of soluble CD 14 in serum of patients with systemic lupus erythematosus
Nockher, W. A., Wigand, R., Schoeppe, W., & Scherberich, J. E. (1994) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06222.x · Cited by 112
Egerer, K., Feist, E., Rohr, U., Prüß, A., Burmester, G. R., & Dörner, T. (2000) · Lupus · doi:10.1191/096120300678828749 · Cited by 109
Expression of CD14 by Hepatocytes: Upregulation by Cytokines during Endotoxemia
Liu, S., Khemlani, L. S., Shapiro, R. A., Johnson, M. L., Liu, K., Geller, D. A., Watkins, S. C., Goyert, S. M., & Billiar, T. R. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5089-5098.1998 · Cited by 105
Molecular basis of host—pathogen interaction in septic shock
Heumann, D., Glauser, M. P., & Calandra, T. (1998) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(98)80142-2 · Cited by 104
Soler-Rodriguez, A. M., Zhang, H., Lichenstein, H. S., Qureshi, N., Niesel, D. W., Crowe, S. E., Peterson, J. W., & Klimpel, G. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2674 · Cited by 100
CD14-dependent clearance of apoptotic cells by human macrophages: the role of phosphatidylserine
Devitt, A., Pierce, S., Oldreive, C., Shingler, W. H., & Gregory, C. D. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401168 · Cited by 99
CD14 expression and production by human hepatocytes
Su, G. L., Dorko, K., Strom, S. C., Nussler, A. K., & Wang, S. C. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80034-8 · Cited by 98
Schumann, R. R., Rietschel, E. T., & Loppnow, H. (1994) · Medical Microbiology and Immunology · doi:10.1007/bf00196679 · Cited by 92
Sugawara, S., Sugiyama, A., Nemoto, E., Rikiishi, H., & Takada, H. (1998) · Infection and Immunity · doi:10.1128/iai.66.7.3043-3049.1998 · Cited by 90
Thomas, C. J., Kapoor, M., Sharma, S., Bausinger, H., Ziylan, U., Lipsker, D. M., Hanau, D., & Surolia, A. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03499-3 · Cited by 80
Arias, M. A., Nores, J. E. R., Vita, N., Stelter, F., Borysiewicz, L. K., Ferrara, P., & Labéta, M. O. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3480 · Cited by 76
Pan, Z., Zhou, L., Hetherington, C. J., & Zhang, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003192200 · Cited by 74
CD14 and Immune Response to Lipopolysaccharide
Maliszewski, C. R. (1991) · Science · doi:10.1126/science.1718034 · Cited by 74
Gabay, C., Porter, B., Fantuzzi, G., & Arend, W. P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.12.5905 · Cited by 67
Self-citationGabay, C., Porter, B. B., Guenette, D. K., Billir, B., & Arend, W. P. (1999) · Blood · doi:10.1182/blood.v93.4.1299 · Cited by 66
Self-citationSmith, J. W., & McDonald, T. L. (1992) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb07945.x · Cited by 63
Oesterreicher, C., Pfeffel, F., Petermann, D., & Müller, C. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80197-9 · Cited by 55
Increased levels of circulating soluble CD14 in Kawasaki disease
Takeshita, S., Nakatani, K., Tsujimoto, H., Kawamura, Y., Kawase, H., & Sekine, I. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01120.x · Cited by 49
Yu, S., Nakashima, N., Xu, B., Matsuda, T., Izumihara, A., Sunahara, N., Nakamura, T., Tsukano, M., & Matsuyama, T. (1998) · Rheumatology International · doi:10.1007/s002960050041 · Cited by 42
Gabay, C., Genin, B., Mentha, G., Iynedjian, P. B., Roux-Lombard, P., & Guerne, P. A. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03669.x · Cited by 40
Self-citationsCD14 prevents endotoxin inducible oxidative burst response of human monocytes.
Schütt, C., Schilling, T., & Krüger, C. L. (1991) · PubMed · Cited by 29
Response : CD14 and Immune Response to Lipopolysaccharide
Wright, S. D. (1991) · Science · doi:10.1126/science.252.5010.1321.b · Cited by 22
Cited by
TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling
Ciesielska, A., Matyjek, M., & Kwiatkowska, K. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03656-y · Cited by 1,420
Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection
Messner, C. B., Demichev, V., Wendisch, D., Michalick, L., White, M., Freiwald, A., Textoris-Taube, K., Vernardis, S. I., Egger, A.-S., Kreidl, M., et al. (2020) · Cell Systems · doi:10.1016/j.cels.2020.05.012 · Cited by 561
Hepatocytes: a key cell type for innate immunity
Zhou, Z., Xu, M.-J., & Gao, B. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.97 · Cited by 472
Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation
Laugerette, F., Vors, C., Géloën, A., Chauvin, M.-A., Soulage, C., Lambert-Porcheron, S., Peretti, N., Alligier, M., Burcelin, R., Laville, M., et al. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.11.011 · Cited by 290
Endotoxemia—menace, marker, or mistake?
Munford, R. S. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ru0316-151r · Cited by 219
“High soluble CD14 levels have been found in patients with rheumatological diseases [107], following total hip replacement [109], and with other conditions.”
Background
Metadata
- Authors
- Bas, S., Gauthier, B. R., Spenato, U., Stingelin, S., & Gabay, C.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-04-01
- Volume
- 172
- Issue
- 7
- Pages
- 4470-4479
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1658974469
- Cited by
- 263
- References
- 72
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.